Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

All MBC

• • Cancer Support Community Online Survey: The Cancer Experience Registry

Triple Negative

• • ADCT-301 in Patients With Advanced Triple Negative Breast Cancer  
  • Anetumab Ravtansine in Advanced Triple Negative Tumors That Are Mesothelin-Positive  
  • A Vaccine-Based Immunotherapy For Stage IV Triple Negative Breast Cancer 
  • Durvalumab & Olaparib in Advanced Triple Negative Breast Cancer Treated with Chemotherapy
  • LAG525 plus Spartalizumab or Carboplatin in Advanced Triple-Negative Breast Cancer
  • Tavo and Pembrolizumab (Immunotherapy) in Advanced Triple Negative Tumors  

BRCA1/2 Mutation

• • Lurbinectedin to Treat Metastatic Breast Cancer in Women & Men with BRCA1/2 Mutations 

Brain Metastasis

• • Methotrexate in Patients With Metastatic Breast Cancer and Leptomeningeal Metastasis 
  • Pembrolizumab (Immunotherapy) And Radiosurgery (Radiation) to Treat Brain Metastases

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.